-The Hindu Business Line Govt wants to keep issues of national importance outside purview of the law New Delhi: Is the Centre diluting the Whistleblower Protection Law by excluding certain issues of national importance from its purview? It appears so, going by the latest Amendment Bill, which was introduced in the Lok Sabha on Monday. A likely effect of the new Bill is that whistleblowers seeking to raise issues of national importance, including those...

-Business Standard Amendments will bar whistleblowers from disclosing info which govt and its agencies are exempted from providing under RTI Act The NDA government has proposed to substantially reduce the kind of information the whistle-blowers will be able to disclose under the Whistleblowers Protection Act, 2011. The government has tabled an amendment bill in the Lok Sabha that reduces the mandate of the law considerably. If the amendment is passed, the whistle-blower would no...

-The Tribune The biggest lesson of the last 10 years since the Right to Information Act came into force is that Indian democracy, if it has to be meaningful, has to have a strong, effective RTI regime. That regime has to be equally owned by those who govern and those who are governed. TEN years after the Right to Information Act promised the country a "practical regime of right to information for...

-The Indian Express For a government that won office on the plank of fighting corruption and promising ‘‘achhe din'' to citizens disgruntled by poor service delivery, one would have thought putting in place an effective anti-corruption and grievance redressal framework would be a top priority. However, after 100 days of being in power, the Modi sarkar's report card on transparency and accountability disappoints. It is well established that openness in government functioning...

-The Hindu A strong whistle-blower protection law in India would expose financial corruption in a way that reinforces ethical business practices In 2013, generic pharmaceutical company Ranbaxy pleaded guilty to seven criminal felonies for drug manufacturing fraud and agreed to cough up an unprecedented $500 million in fines. The case against Ranbaxy was significant not only for being a successful prosecution of a powerful India corporation. It also marked the triumph of Dinesh...